Literature DB >> 13330473

[Oral therapy of diabetes mellitus by N-tolyl-sulfonyl-N'-butyl urea (D 860); clinical and experimental studies].

A BANDER, W CREUTZFELDT, T DORFMULLER, H EHRHART, R MARX, H MASKE, W MEIER, G MOHNIKE, E F PFEIFFER, S SCHLAGINTWEIT, K SCHOFFLING, J SCHOLZ, I SEIDLER, H STEIGERWALD, W STICH, G STOTTER, H ULRICH.   

Abstract

Entities:  

Keywords:  DIABETES MELLITUS/therapy; SULFONAMIDES/therapeutic use; UREA/derivatives

Mesh:

Substances:

Year:  1956        PMID: 13330473     DOI: 10.1055/s-0028-1115797

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


× No keyword cloud information.
  5 in total

1.  The fiftieth anniversary of hypoglycaemic sulphonamides. How did the mother compound work?

Authors:  J C Henquin
Journal:  Diabetologia       Date:  1992-10       Impact factor: 10.122

2.  [On the determination of insulin in the blood through the epididymal fat accumulation of the rat with aid of labelled glucose. III. The effect of sulfonylurea and biguanide (DBI) on canbohydrate metabolism of isolated fatty tissue and diaphragm of the rat].

Authors:  H DITSCHUNEIT; E F PFEIFFER; H G ROSSENBECK
Journal:  Klin Wochenschr       Date:  1961-01-15

3.  TOLBUTAMIDE in diabetes.

Authors: 
Journal:  Br Med J       Date:  1957-08-10

4.  Trial of an oral hypoglycaemic agent in diabetes.

Authors:  F W WOLFF; G A STEWART; M F CROWLEY; A BLOOM
Journal:  Br Med J       Date:  1956-08-25

5.  [4-methylbenzenesulfonyl]-N'-butylurea (D 860) and insulin on the incorporation of C14-labelled carbon dioxide into liver glycogen].

Authors:  H D SUMM; W CREUTZFELDT; K WALLENFELS
Journal:  Klin Wochenschr       Date:  1960-01-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.